España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Large Cap
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
Chicken Tax 2.0: Bank Of America Flags 3 Million Sales At Risk After Auto Tariffs
Gold Grinds Higher, Wall Street Falls As Tariff-Inflation Combo Hammer End-Of-Week Risk Appetite
Chicken Tax 2.0: Bank Of America Flags 3 Million Sales At Risk After Auto Tariffs
Gold Grinds Higher, Wall Street Falls As Tariff-Inflation Combo Hammer End-Of-Week Risk Appetite
India Targets SQM's Australian Lithium To Diversify Its Imports
'Our GPUs Are Melting,' OpenAI's Altman Warns — Could US Natural Gas Power AI Revolution?
India Targets SQM's Australian Lithium To Diversify Its Imports
'Our GPUs Are Melting,' OpenAI's Altman Warns — Could US Natural Gas Power AI Revolution?
Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer
Stocks Slide As Auto Tariffs Boost Tesla, Rivian And Hit GM, Ford: What's Driving Markets Thursday?
Read More...
Large Cap Recent News
FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool
FDA approves Novartis' Pluvicto for advanced prostate cancer patients who have received ARPI therapy.
Cathie Wood Doubles Down On $2,600 Tesla Stock Price Prediction
CEO of Ark Invest Cathie Wood reaffirmed her bullish $2,600 price target on Tesla despite the stock's 32% decline year-to-date in 2025.
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential milestone payments of up to $1 billion.
Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug
BridgeBio's acoramidis wins Japan's approval for ATTR-CM. Phase 3 data show a 42% reduction in key heart-related events. AstraZeneca's Alexion to market it.
Trump Slaps 25% Tariffs On Autos: What It Means For Your Next Car Purchase
Experts are warning consumers to prepare for additional price hikes due to President Donald Trump's new 25% tariff on imported vehicles and certain auto parts.
Repsol, NEO Energy Join Forces In North Sea Deal, Targeting $1 Billion In Synergies (CORRECTED)
Repsol Resources UK merges with NEO Energy to form NEO NEXT Energy Limited, creating a major independent producer in the North Sea with potential for significant growth and value for shareholders.
Why Is Tesla's Chinese Rival NIO Stock Diving Today? (UPDATED)
NIO shares decline amid news that White House announced new tariffs on auto imports. The company plans to offer 118.8 million shares to fund R&D and strengthen balance sheet.
Trump's 25% Tariff Set To Hike Imported Car Prices Up To $15,000 Higher, Goldman Sachs Warns
IFF Joins Forces With Kemira For Joint Venture Focused On Biopolymer Production
IFF shares up on joint venture with Kemira to produce sustainable biobased materials in Finland, using IFF's DEB platform technology.
BP Sells Austrian Mobility Business, Finalizes Redevelopment Deal For Kirkuk Fields In Iraq
BP plans to sell its mobility and convenience business in Austria, including 260 retail sites, as part of its strategy to reshape downstream operations.
Broadcom Powers Audi's Smart Factory Push with VMware Cloud: Details
Broadcom teams up with Audi to launch the Edge Cloud 4 Production initiative powered by VMware software, aiming to improve factory automation and reduce hardware and manual operations.
TD SYNNEX Slides As Q1 Misses On Revenue And EPS, Cash Flow Turns Deeply Negative
TD SYNNEX reported Q1 results with revenue of $14.53B, up 4.0% Y/Y but missing estimates. Adjusted EPS of $2.80 and outlook below estimates.
GE Aerospace Lands Major Korean Air Deal: GEnx And GE9X Engines To Power New Boeing Fleet
Korean Air orders GEnx and GE9X engines for new fleet of Boeing 777-9s and 787-10s, with a service agreement. GE9X is most powerful and fuel-efficient engine.